BIOLASE, Inc. (OTCQB:BIOL) Q2 2020 Earnings Conference Call August 13, 2020 4:30 PM ET Company Participants Todd Kehrli - The EVC Group Todd Norbe - Chief Executive Officer John Beaver - Chief Financial Officer Conference Call Participants Kyle Bauser - Colliers Securities Bruce Jackson - Benchmark Company Ed Woo - Ascendiant Capital Operator Good day, and welcome to the BIOLASE 2020 Second Quarter Financial Results Conference Call. Today's conference is being recorded. And at this time, I would like to tur ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 BIOLASE, INC. (Exact name of registrant as specified in its charter) FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36385 Delaware 87-0442441 (State or other jurisdiction of incorporatio ...

BIOLASE Inc (OTCQB:BIOL) Q1 2020 Results Conference Call May 7, 2020 4:30 PM ET Company Participants Todd Kehrli - The EVC Group Todd Norbe - Chief Executive Officer John Beaver - Chief Financial Officer Conference Call Participants Bruce Jackson - The Benchmark Company Kyle Bauser - Dougherty & Company Ed Woo - Ascendiant Capital Operator Good day, and welcome to the BIOLASE 2020 First Quarter Financial Results Conference Call. Today's conference is being recorded. At this time, I would like to turn the c ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 BIOLASE, INC. (Exact name of registrant as specified in its charter) FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36385 Delaware 87-0442441 (State or other jurisdiction of incorporati ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36385 BIOLASE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 87-0442441 (State or Other Jurisdiction of Incorpor ...

BIOLASE, Inc. (OTCQB:BIOL) Q4 2019 Earnings Conference Call March 26, 2020 4:30 PM ET Company Participants Todd Kehrli - EVC Group Todd Norbe - President and Chief Executive Officer John Beaver - Executive Vice President and Chief Financial Officer Conference Call Participants Kyle Bauser - Dougherty Bruce Jackson - The Benchmark Company Ed Woo - Ascendiant Capital Operator Good day and welcome to the BIOLASE 2019 Fourth Quarter and Year End Financial Results Conference Call. Today's conference is being re ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock at par value $0.001 per share BIOL The NASDAQ Stock Market LLC (NASDAQ Capital Market) FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 1 ...

BIOLASE, Inc. (OTCQB:BIOL) Q3 2019 Earnings Conference Call November 6, 2019 4:30 PM ET Company Participants Todd Kehrli - EVC Group Todd Norbe - President and CEO John Beaver - EVP and CFO Conference Call Participants Kyle Bauser - Dougherty Bruce Jackson - The Benchmark Company Ed Woo - Ascendiant Capital Lisa Springer - Singular Research Operator Good day everyone, and welcome to the BIOLASE 2019 Third Quarter Financial Results Conference Call. Today's call is being recorded. At this time, I would like t ...

| --- | --- | --- | --- | |--------------------|--------------------------------|-----------------------|-------| | | | | | | | | | | | | | INVESTOR PRESENTATION | | | Waterlase Express™ | NASDAQ CM: BIOL September 2019 | | | Safe Harbor Statement Statements made in this presentation and during discussions with BIOLASE representative's that refer to BIOLASE's estimated or anticipated future results or other non-historical facts are forward-looking statements, as are any statements its representatives make c ...

BIOLASE, Inc. (OTCQB:BIOL) Q2 2019 Results Earnings Conference Call August 8, 2019 4:30 PM ET Company Participants Todd Kehrli - EVC Group Todd Norbe - President and CEO John Beaver - EVP and CFO Conference Call Participants Kyle Bauser - Dougherty & Company Bruce Jackson - Benchmark Company Lisa Springer - Singular Research Operator Good day, everyone, and welcome to the BIOLASE 2019 Second Quarter Financial Results Conference Call. Today's conference is being recorded. At this time, I would like to turn t ...